Yerevan
EN
Complex
40-625

Calculation of MELD and MELDNa prognostic model scores for patient survival with end-stage chronic diffuse liver disease

Description

MELD (Model for End-Stage Liver Disease) is a scoring system that helps to assess the severity of chronic liver disease and the risk of mortality within the next 3 months. It is used to prioritize patients waiting for a liver transplant. MELDNa is an improved version of this scale. It takes into account another important factor—the level of sodium in the blood.

Period of execution

By 00:00 the next day. The specified time does not include the day of biomaterial collection

Biomaterial type

  • Venous blood
Total price
5420 ֏
Lab tests
Lab tests
Discounts
Discounts
Addresses
Addresses